1st Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for AMGEN, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; S. 2543 - The Prescription Drug Price Reduction Act; H.R. 3 - Lower Drug Costs Now Act of 2019; Part B home infusion; H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ New Chief of Staff, Rep. Melissa Bean (2005-2009); Chief of Staff, Rep. Chris Bell (2003-2005)
JAY HEIMBACH New Special Asst. to the President for Leg. Affairs (2009-2011); Chief of Staff, Sen. Sherrod Brown (2007-2009); Office of Leg & Intergovernmental Affairs, FCC (1999-2001)
JONATHON JONES New Chief of Staff, Sen. Tom Carper (2001-2006); Legislative Director, Sen. Tom Carper (2001)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (117th), H.R. 133 (117th), H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.